IndraLab

Statements


Mutated BAP1 inhibits UK. 1 / 1
| 1

reach
"This study therefore suggests that complete loss-of-function germline BAP1 mutations underlie susceptibility to cutaneous melanoma in ~ 0.2% of the population ascertained melanoma cases in the UK."